Research Ties TMAO Pathway to Chronic Kidney Disease
Large-scale joint study shows striking link between high blood levels of TMAO and chronic kidney disease risk over time.
Large-scale joint study shows striking link between high blood levels of TMAO and chronic kidney disease risk over time.
The 8th Cutter Symposium focused on one of the major challenges of obtaining accurate results in nutrition studies—the role of hidden, so-called confounding factors in…
The fellows discussed how to choose a career path, what makes a good mentor, and more.
The event was hosted by James Spratt, St George’s University Hospital NHS Trust, London, UK with and Emanuele Barbato Sant Andrea Hospital, Rome, IT in…
A new study recorded data on the type of treatment received in each line of therapy for advanced urothelial carcinoma, as well as the attrition…
Patients who received Orca-T had “superior” all-grade chronic GVHD-free survival after allogeneic HSCT compared with those recieved PTCy.
The Oncology Brothers are joined by Nina Sanford, MD; Jeffrey M. Ryckman, MD; and Harris Chengazi, MD, to discuss the treatment of patients with hepatocellular…
There is a “lack of consistency” among patient-reported outcome (PRO) measures used to evaluate treatments for chronic myeloid leukemia (CML), according to a new study.
Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator…
Dr. Mike talks with Bryan Johnson about his quest to live as long as possible
Study finds that risk of death for heart attack patients significantly reduced by treatment